VIVSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends March 31
VivoSim Labs, INC.
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$0.16+0.00 (+0.38%)
Close on Oct 19, 2026
- Market cap
- $825.22K
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
0.7%
0M of 15M shares
Institutional holders
26
5 new, 3 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
1 buys · 1 sales
Net sold $4.52K
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Esousa Group Holdings LLC | 319,429 | 9.90% | 13G (passive) amendment | Jun 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of VIVS | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 25,976 | 0.17% | $27.80K | −10,874 | 0.00% |
| Renaissance Technologies LLC | 18,500 | 0.12% | $19.80K | New | 0.00% |
| Hrt Financial LP | 18,319 | 0.12% | $19 | New | 0.00% |
| Vanguard Capital Management LLC | 15,371 | 0.10% | $16.45K | – | 0.00% |
| BlackRock, Inc. | 11,817 | 0.08% | $12.64K | – | 0.00% |
| Vanguard Fiduciary Trust Co | 7,003 | 0.05% | $7.49K | – | 0.00% |
| Tower Research Capital LLC (TRC) | 5,249 | 0.04% | $5.62K | +2,941 | 0.00% |
| SBI Securities Co., Ltd. | 221 | 0.00% | $236 | – | 0.00% |
| FNY Investment Advisers, LLC | 200 | 0.00% | $0 | New | 0.00% |
| Larson Financial Group LLC | 166 | 0.00% | $178 | – | 0.00% |
| Albion Financial Group /Ut | 159 | 0.00% | $171 | – | 0.00% |
| Wells Fargo & Company/Mn | 111 | 0.00% | $119 | – | 0.00% |
| Osaic Holdings, Inc. | 84 | 0.00% | $88 | −11 | 0.00% |
| Morgan Stanley | 49 | 0.00% | $52 | −1 | 0.00% |
| UBS Group AG | 18 | 0.00% | $20 | −934 | 0.00% |
| Caitong International Asset Management Co., Ltd | 17 | 0.00% | $18 | +14 | 0.00% |
| IFG Advisory, LLC | 14 | 0.00% | $15 | New | 0.00% |
| Integrated Wealth Concepts LLC | 8 | 0.00% | $9 | New | 0.00% |
| Activest Wealth Management | 2 | 0.00% | $2 | – | 0.00% |
| Golden State Wealth Management, LLC | 2 | 0.00% | $2 | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 26 | 0M | 0.7% | 5 / 2 | 5 / 3 | 0M | 0M |
| Q1 2026 | 24 | 0M | 0.7% | 5 / 4 | 2 / 7 | 0M | 0M |
| Q4 2025 | 27 | 0M | 0.7% | 5 / 3 | 6 / 7 | 0M | 0M |
| Q3 2025 | 29 | 0M | 1.5% | 11 / 7 | 4 / 8 | 0M | 0M |
| Q2 2025 | 26 | 0M | 0.9% | 8 / 5 | 3 / 5 | 0M | 0M |
| Q1 2025 | 23 | 0M | 0.4% | 23 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of VIVS | Value | % of fund | As of |
|---|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 24,544 | 0.17% | $32.15K | 0.00% | May 31, 2026 |
| Vanguard Extended Market Index Fund | 15,371 | 0.10% | $16.45K | 0.00% | Jun 30, 2026 |
| Fidelity Series Total Market Index Fund | 4,055 | 0.03% | $5.31K | 0.00% | May 31, 2026 |
| Fidelity Total Market Index Fund | 991 | 0.01% | $1.30K | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Keith Murphy | EXECUTIVE CHAIRMAN, Director | 6,094,968 | 41.04% | Jan 29, 2026 |
| Tony Serge Lialin | Chief Commercial Officer | 10,000 | 0.07% | Sep 1, 2026 |
| Amar Akhtar Sethi | Chief Scientific Officer | – | – | Nov 26, 2025 |
| Norm Staskey | See Remarks | – | – | Jan 8, 2025 |
| David Gobel | Director | 15,000 | 0.10% | Jan 29, 2026 |
| Douglas Jay Cohen | Director | 20,898 | 0.14% | Jan 29, 2026 |
| Adam K. Stern | Director | 522,988 | 3.52% | Jan 29, 2026 |
| Alison Tjosvold Milhous | Director | 19,899 | 0.13% | Jan 29, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Tony Serge Lialin Chief Commercial Officer | Aug 31, 2026 | Buy | +10,000 | $0.28 | $2.80K | 10,000 |
| Keith Murphy EXECUTIVE CHAIRMAN, Director | Jan 27, 2026 | Award | +15,000 | – | – | 26,053 |
| Alison Tjosvold Milhous Director | Jan 27, 2026 | Award | +15,000 | – | – | 19,899 |
| Adam K. Stern Director | Jan 27, 2026 | Award | +15,000 | – | – | 19,899 |
| David Gobel Director | Jan 27, 2026 | Award | +15,000 | – | – | 15,000 |
| Douglas Jay Cohen Director | Jan 27, 2026 | Award | +15,000 | – | – | 20,732 |
| David Gobel Director | Nov 17, 2025 | Sale | +3,266 | $2.24 | $7.32K | 0 |
| David Gobel Director | Aug 7, 2024 | Award | +19,607 | – | – | 39,214 |
| Douglas Jay Cohen Director | Aug 7, 2024 | Award | +19,607 | – | – | 68,821 |
| Alison Tjosvold Milhous Director | Aug 7, 2024 | Award | +19,607 | – | – | 58,821 |
| Adam K. Stern Director | Aug 7, 2024 | Award | +19,607 | – | – | 58,821 |
| Vaidehi Joshi Director | Aug 7, 2024 | Award | +19,607 | – | – | 58,821 |
| Keith Murphy EXECUTIVE CHAIRMAN, Director | Aug 7, 2024 | Award | +19,607 | – | – | 132,641 |
| Alison Tjosvold Milhous Director | Nov 17, 2023 | Award | +19,607 | – | – | 39,214 |
| Keith Murphy Executive Chairman, Director | Nov 17, 2023 | Award | +19,607 | – | – | 113,034 |
| Douglas Jay Cohen Director | Nov 17, 2023 | Award | +19,607 | – | – | 49,214 |
| David Gobel Director | Nov 17, 2023 | Award | +19,607 | – | – | 19,607 |
| Vaidehi Joshi Director | Nov 17, 2023 | Award | +19,607 | – | – | 39,214 |
| Adam K. Stern Director | Nov 17, 2023 | Award | +19,607 | – | – | 39,214 |
| David Gobel Director | Nov 15, 2023 | Sale | −19,607 | $1.62 | $31.76K | 0 |
| Alison Tjosvold Milhous Director | Nov 10, 2022 | Award | +19,607 | – | – | 19,607 |
| Douglas Jay Cohen Director | Nov 10, 2022 | Award | +19,607 | – | – | 29,607 |
| Adam K. Stern Director | Nov 10, 2022 | Award | +19,607 | – | – | 19,607 |
| Keith Murphy Executive Chairman, Director | Nov 10, 2022 | Award | +19,607 | – | – | 93,427 |
| Vaidehi Joshi Director | Nov 10, 2022 | Award | +19,607 | – | – | 19,607 |
| David Gobel Director | Nov 10, 2022 | Award | +19,607 | – | – | 19,607 |
| David Gobel Director | Nov 19, 2021 | Sale | −145 | $5.29 | $767 | 0 |
| Douglas Jay Cohen Director | Aug 17, 2021 | Buy | +1,000 | $6.72 | $6.72K | 1,000 |
| Douglas Jay Cohen Director | Aug 17, 2021 | Buy | +1,000 | $6.74 | $6.74K | 1,000 |
| Douglas Jay Cohen Director | Aug 17, 2021 | Buy | +8,750 | $6.72 | $58.80K | 10,000 |
| Keith Murphy Executive Chairman, Director | Mar 8, 2021 | Award | +20,000 | – | – | 66,320 |
| Jennifer Bush General Counsel & Secretary | Aug 18, 2020 | Tax withholding | −10,900 | $0.57 | $6.21K | 192,758 |
| Craig Kussman Chief Financial Officer | Aug 18, 2020 | Tax withholding | −15,700 | $0.57 | $8.95K | 221,743 |
| Taylor Crouch CEO & President, Director | Aug 18, 2020 | Tax withholding | −5,510 | $0.57 | $3.14K | 125,144 |
| Jennifer Bush General Counsel & Secretary | May 18, 2020 | Tax withholding | −14,630 | $0.51 | $7.46K | 203,658 |
| Taylor Crouch CEO & President, Director | May 18, 2020 | Tax withholding | −6,340 | $0.51 | $3.23K | 130,654 |
| Craig Kussman Chief Financial Officer | May 18, 2020 | Tax withholding | −18,030 | $0.51 | $9.20K | 237,443 |
| Craig Kussman Chief Financial Officer | Feb 19, 2020 | Tax withholding | −17,100 | $0.32 | $5.47K | 255,473 |
| Taylor Crouch CEO & President, Director | Feb 19, 2020 | Tax withholding | −6,045 | $0.32 | $1.93K | 136,994 |
| Jennifer Bush General Counsel & Secretary | Feb 19, 2020 | Tax withholding | −13,850 | $0.32 | $4.43K | 218,288 |
| Jennifer Bush General Counsel & Secretary | Nov 18, 2019 | Tax withholding | −11,695 | $0.45 | $5.26K | 232,138 |
| Craig Kussman Chief Financial Officer | Nov 18, 2019 | Tax withholding | −14,410 | $0.45 | $6.48K | 272,573 |
| Taylor Crouch CEO & President, Director | Nov 18, 2019 | Tax withholding | −5,075 | $0.45 | $2.28K | 143,039 |
| Paul Gallant General Manager | Aug 16, 2019 | Tax withholding | −9,500 | $0.29 | $2.76K | 191,335 |
| Craig Kussman Chief Financial Officer | Aug 16, 2019 | Tax withholding | −14,750 | $0.29 | $4.28K | 286,983 |
| Steven George Hughes Chief Medical Officer | Aug 16, 2019 | Sale | −22,230 | $0.29 | $6.45K | 138,484 |
| Jennifer Bush General Counsel & Secretary | Aug 16, 2019 | Tax withholding | −11,960 | $0.29 | $3.47K | 243,833 |
| Taylor Crouch CEO & President, Director | Aug 16, 2019 | Tax withholding | −5,300 | $0.29 | $1.54K | 148,114 |
| Craig Kussman Chief Financial Officer | May 16, 2019 | Tax withholding | −15,155 | $0.97 | $14.70K | 301,733 |
| Jennifer Bush General Counsel & Secretary | May 16, 2019 | Tax withholding | −12,275 | $0.97 | $11.91K | 255,793 |
| Paul Gallant General Manager | May 16, 2019 | Tax withholding | −9,274 | $0.97 | $9.00K | 200,835 |
| Taylor Crouch CEO & President, Director | May 16, 2019 | Tax withholding | −5,465 | $0.97 | $5.30K | 153,414 |
| Paul Gallant General Manager | Feb 19, 2019 | Tax withholding | −10,410 | $1.07 | $11.14K | 210,109 |
| Jennifer Bush General Counsel & Secretary | Feb 19, 2019 | Tax withholding | −13,520 | $1.07 | $14.47K | 268,068 |
| Taylor Crouch CEO & President, Director | Feb 19, 2019 | Tax withholding | −5,665 | $1.07 | $6.06K | 158,879 |
| Craig Kussman Chief Financial Officer | Feb 19, 2019 | Tax withholding | −16,215 | $1.07 | $17.35K | 316,888 |
| Paul Gallant General Manager | Nov 16, 2018 | Tax withholding | −9,450 | $1.07 | $10.11K | 220,519 |
| Jennifer Bush General Counsel & Secretary | Nov 16, 2018 | Tax withholding | −11,915 | $1.07 | $12.75K | 281,588 |
| Taylor Crouch CEO & President, Director | Nov 16, 2018 | Tax withholding | −5,140 | $1.07 | $5.50K | 164,544 |
| Craig Kussman Chief Financial Officer | Nov 16, 2018 | Tax withholding | −14,720 | $1.07 | $15.75K | 333,103 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| David Gobel Director | Nov 15, 2023 | 19,607 | $31.75K | Nov 15, 2023 | RSU GRAN VEST |